Home Compliance DOJ Files Complaint in AWP False Claims Act Suit Against Pharmaceutical Ingredient... ComplianceExpert OpinionFCANews DOJ Files Complaint in AWP False Claims Act Suit Against Pharmaceutical Ingredient Seller November 18, 2021 23 Share FacebookLinkedinTwitter ShotPrime Studio | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance The Defendant’s Use of Medical Equipment May Have Been Unhygienic, But It Didn’t Amount to an FCA Violation Compliance This Article Could Ruin Your Qui Tam Suit: “News Media” in FCA’s Public Disclosure Bar Includes Blog Posts Compliance Aerospace & Defense Insights | Roadmap for False Claims Act Enforcement in 2024